Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
NCT ID: NCT00195611
Last Updated: 2010-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3293 participants
OBSERVATIONAL
2005-09-30
2006-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nasopharyngeal Carriage of S. Pneumoniae
NCT04460313
Effect of Prevnar 13 on Ear Infections in Children
NCT01199016
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
NCT00370396
Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®
NCT00488371
Impact of Prevnar 13 on Ear Infections in Children
NCT01272999
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prevenar
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presenting with AOM (ear infection)
* Patients must not have received any antibiotic therapy within the past 7 days.
Other inclusion applies.
6 Months
24 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Monitor
Role: STUDY_DIRECTOR
Wyeth is now a wholly owned subsidiary of Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Auch, , France
Brest, , France
Canne La Boca, , France
Chambéry, , France
Châlons-en-Champagne, , France
Combs-la-Ville, , France
Créteil, , France
Draguignan, , France
Essey-lès-Nancy, , France
Fontenay-sous-Bois, , France
Grenoble, , France
Grigny, , France
Lagny, , France
Les Lilas, , France
Les Ulis, , France
Lyon, , France
Marquette-lez-Lille, , France
Marseille, , France
Massy, , France
Molsheim, , France
Paris, , France
Paris, , France
Paris, , France
Paris, , France
Paris, , France
Rouen, , France
Saint-Brieuc, , France
Saint-Maur-des-Fossés, , France
Sélestat, , France
Thionville, , France
Toulouse, , France
Tours, , France
Vandœuvre-lès-Nancy, , France
Vence, , France
Villeneuve-lès-Avignon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0887X-100918
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.